Multipurpose Reagent Tests
In a final rule relating to the Health Insurance Portability and Accountability Act (HIPAA), a patient or their personal representative can access their completed test reports directly from the laboratory.
Two diagnostic panels based on microRNA expression from whole blood can distinguish, to some degree, patients with pancreatic cancer from healthy controls.
The FDA allowed marketing of four "next generation sequencing" (NGS) diagnostic devices. These devices can be used for high throughput patient gene sequencing to help with diagnosis and identification of the cause of symptoms.
Quidel Corporation and Life Technologies announced that the FDA has granted clearance to the Quidel Molecular Influenza A+B assay and the Quidel Molecular RSV+hMPV assay.
Primary care practitioners (PCPs) using electronic health records (EHRs) are susceptible to information overload and feel that the EHR notification system makes it possible to miss test results